Evis Harja

2.5k total citations
20 papers, 2.0k citations indexed

About

Evis Harja is a scholar working on Clinical Biochemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Evis Harja has authored 20 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Clinical Biochemistry, 8 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Evis Harja's work include Advanced Glycation End Products research (9 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and S100 Proteins and Annexins (3 papers). Evis Harja is often cited by papers focused on Advanced Glycation End Products research (9 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and S100 Proteins and Annexins (3 papers). Evis Harja collaborates with scholars based in United States, Austria and United Kingdom. Evis Harja's co-authors include Ann Marie Schmidt, Barry I. Hudson, Anastasia Z. Kalea, Yan Lü, Shi Fang Yan, Loredana Bucciarelli, Maria Arriero, Éric Boulanger, María del Mar Arriero and Vivette D. D’Agati and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Evis Harja

19 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evis Harja United States 17 1.1k 595 424 369 258 20 2.0k
Marie‐Paule Wautier France 22 989 0.9× 582 1.0× 529 1.2× 276 0.7× 247 1.0× 36 2.5k
Luis Ferran United States 5 1.1k 1.1× 402 0.7× 556 1.3× 305 0.8× 87 0.3× 5 1.9k
A.M. Schmidt United States 6 1.3k 1.2× 564 0.9× 625 1.5× 298 0.8× 112 0.4× 6 2.0k
Sybille Franke Germany 27 1.2k 1.1× 731 1.2× 603 1.4× 152 0.4× 66 0.3× 63 2.5k
Usha Panchapakesan Australia 22 321 0.3× 593 1.0× 681 1.6× 300 0.8× 115 0.4× 32 1.8k
Max H. Stickland United Kingdom 25 638 0.6× 313 0.5× 605 1.4× 173 0.5× 716 2.8× 50 2.5k
Wai Han Yiu Hong Kong 23 260 0.2× 787 1.3× 207 0.5× 467 1.3× 120 0.5× 53 2.1k
Sumant S. Chugh United States 21 211 0.2× 777 1.3× 211 0.5× 229 0.6× 118 0.5× 40 2.2k
Bieke F. Schrijvers Denmark 15 308 0.3× 499 0.8× 306 0.7× 104 0.3× 181 0.7× 18 1.5k
M.-P. Wautier France 17 735 0.7× 242 0.4× 411 1.0× 105 0.3× 178 0.7× 32 1.4k

Countries citing papers authored by Evis Harja

Since Specialization
Citations

This map shows the geographic impact of Evis Harja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evis Harja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evis Harja more than expected).

Fields of papers citing papers by Evis Harja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evis Harja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evis Harja. The network helps show where Evis Harja may publish in the future.

Co-authorship network of co-authors of Evis Harja

This figure shows the co-authorship network connecting the top 25 collaborators of Evis Harja. A scholar is included among the top collaborators of Evis Harja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evis Harja. Evis Harja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwak, Taekyoung, et al.. (2016). Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function. Journal of Biological Chemistry. 291(23). 12057–12073. 27 indexed citations
2.
Güleç, Seza, et al.. (2016). 124 I PET/CT in Patients with Differentiated Thyroid Cancer: Clinical and Quantitative Image Analysis. Thyroid. 26(3). 441–448. 31 indexed citations
3.
Harja, Evis, et al.. (2014). Early And Long Term Outcomes Of Aortic Valve Surgery Combined Or Not With Cabg Surgery. 32–38. 1 indexed citations
4.
Harja, Evis, Jonathan Lord, & Jay S. Skyler. (2013). An Analysis of Characteristics of Subjects Examined for Incretin Effects on Pancreatic Pathology. Diabetes Technology & Therapeutics. 15(8). 609–618. 24 indexed citations
5.
Kalea, Anastasia Z., Fiona See, Evis Harja, et al.. (2010). Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling. Cancer Research. 70(13). 5628–5638. 36 indexed citations
6.
7.
Hudson, Barry I., Anastasia Z. Kalea, María del Mar Arriero, et al.. (2008). Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42. Journal of Biological Chemistry. 283(49). 34457–34468. 299 indexed citations
8.
Harja, Evis, De-xiu Bu, Barry I. Hudson, et al.. (2008). Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice. Journal of Clinical Investigation. 118(1). 183–194. 305 indexed citations
9.
Skoro‐Sajer, Nika, Iréne Lang, Evis Harja, et al.. (2008). A Clinical Comparison of Slow- and Rapid-Escalation Treprostinil Dosing Regimens in Patients with Pulmonary Hypertension. Clinical Pharmacokinetics. 47(9). 611–618. 29 indexed citations
10.
Harja, Evis, Jong Sun Chang, Yan Lü, et al.. (2008). Mice deficient in PKC β and apolipoprotein E display decreased atherosclerosis. The FASEB Journal. 23(4). 1081–1091. 62 indexed citations
11.
Skoro‐Sajer, Nika, Diana Bonderman, Franz Wiesbauer, et al.. (2007). Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. Journal of Thrombosis and Haemostasis. 5(3). 483–489. 97 indexed citations
12.
Hudson, Barry I., Angela M. Carter, Evis Harja, et al.. (2007). Identification, classification, and expression of RAGE gene splice variants. The FASEB Journal. 22(5). 1572–1580. 308 indexed citations
13.
Yan, Shi‐Fang, Evis Harja, Martin Andrassy, Tomoyuki Fujita, & Ann Marie Schmidt. (2006). Protein Kinase C β/Early Growth Response-1 Pathway. Journal of the American College of Cardiology. 48(9). A47–A55. 61 indexed citations
14.
Roth, Georg A., Bernhard Moser, Franziska Roth‐Walter, et al.. (2006). Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. Atherosclerosis. 190(2). 271–281. 102 indexed citations
15.
Hudson, Barry I., et al.. (2006). Alternative splicing of the RAGE gene: analysis and characterization in humans and mice. The FASEB Journal. 20(5).
16.
Bucciarelli, Loredana, Michiyo Kaneko, Radha Ananthakrishnan, et al.. (2006). Receptor for Advanced-Glycation End Products. Circulation. 113(9). 1226–1234. 205 indexed citations
17.
Hofmann, M., Qiong Yang, Evis Harja, et al.. (2005). The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study. Atherosclerosis. 182(2). 301–305. 35 indexed citations
18.
Wendt, Thoralf, Evis Harja, Loredana Bucciarelli, et al.. (2005). RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis. 185(1). 70–77. 185 indexed citations
19.
Andrassy, Martin, Dmitri Belov, Evis Harja, et al.. (2005). Central Role of PKCβ in Neointimal Expansion Triggered by Acute Arterial Injury. Circulation Research. 96(4). 476–483. 21 indexed citations
20.
Harja, Evis, Loredana Bucciarelli, Yan Lü, et al.. (2003). Early Growth Response-1 Promotes Atherogenesis. Circulation Research. 94(3). 333–339. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Paule Wautier Breakdown of academic impact, for papers by Luis Ferran Breakdown of academic impact, for papers by A.M. Schmidt Breakdown of academic impact, for papers by Sybille Franke Breakdown of academic impact, for papers by Usha Panchapakesan Breakdown of academic impact, for papers by Max H. Stickland Breakdown of academic impact, for papers by Wai Han Yiu Breakdown of academic impact, for papers by Sumant S. Chugh Breakdown of academic impact, for papers by Bieke F. Schrijvers Breakdown of academic impact, for papers by M.-P. Wautier
Rankless by CCL
2026